Anssi Vanjoki - Sonova Holding Non-Executive Director
| SONVY Stock | USD 55.91 0.06 0.11% |
Director
Mr. Anssi Vanjoki resigned as NonExecutive Independent Director of Sonova Holding Ltd. with effect from June 2019, a position he has held since June 10, 2009. He was Member of the Audit Committee at the Company. He is Professor at Lappeenranta University of Technology and Individual Multicontributor of RKBS Oy, a technology startup investment company. He was Executive Vice President and General Manager of Nokia until March 2011 and member of the Nokia Group Executive Board from 1998 to 2011. He has a Masters degree in business administration from the Helsinki School of Economics and Business Administration. He is Chairman of the Board of Oriola Corporationrationration, ViceChairman of the board of Elisa Corporation and anchor investor and Chairman of small technology companies. since 2009.
| Age | 62 |
| Tenure | 15 years |
| Phone | 41 58 928 33 33 |
| Web | https://www.sonova.com |
Sonova Holding Management Efficiency
The company has return on total asset (ROA) of 0.0879 % which means that it generated a profit of $0.0879 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2878 %, meaning that it generated $0.2878 on every $100 dollars invested by stockholders. Sonova Holding's management efficiency ratios could be used to measure how well Sonova Holding manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Alan Kozlowski | Orthopediatrics Corp | 51 | |
| Aimee Weisner | Glaukos Corp | 51 | |
| Arthur Rosenthal | LivaNova PLC | 70 | |
| Alan Levine | Axogen Inc | 50 | |
| Andrea Saia | LivaNova PLC | 60 | |
| Donald Spence | Integer Holdings Corp | 67 | |
| Francesco Bianchi | LivaNova PLC | 60 | |
| Austin Adams | Paragon 28 | 71 | |
| David Hoffmeister | Glaukos Corp | 66 | |
| Mark Foley | Glaukos Corp | 55 | |
| Gilbert Kliman | Glaukos Corp | 61 | |
| Elizabeth Nabel | Medtronic PLC | 69 | |
| Marie Infante | Orthopediatrics Corp | 68 | |
| Alvin Jeffers | Integer Holdings Corp | 47 | |
| William Summers | Integer Holdings Corp | 70 | |
| Preetha Reddy | Medtronic PLC | 57 | |
| Kevin Unger | Orthopediatrics Corp | 46 | |
| Jerome Lande | CONMED | 45 | |
| Shirley Jackson | Medtronic PLC | 70 | |
| Amy Wendell | Axogen Inc | 57 | |
| David Pelizzon | Orthopediatrics Corp | 62 | |
Management Performance
| Return On Equity | 0.29 | |||
| Return On Asset | 0.0879 |
Sonova Holding AG Leadership Team
Elected by the shareholders, the Sonova Holding's board of directors comprises two types of representatives: Sonova Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sonova. The board's role is to monitor Sonova Holding's management team and ensure that shareholders' interests are well served. Sonova Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sonova Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stacy Seng, Non-Executive Director | ||
| Robert Woolley, Group Board | ||
| Thomas Bernhardsgruetter, Director Investor Relations | ||
| Ludger Althoff, Vice President - Operations | ||
| Beat Hess, Non-Executive Director | ||
| John Zei, Non-Executive Director | ||
| Robert Spoerry, Non-Executive Chairman of the Board of Directors | ||
| Anssi Vanjoki, Non-Executive Director | ||
| Victoria CarrBrendel, Group Vice President Cochlear Implants and Presidentident of Advanced Bionics and Member of the Management Board | ||
| Sarah Kreienbuehl, Member of the Management Board, Group Vice President Corporate Human Resources | ||
| Hartwig Grevener, CFO and Member of Management Board | ||
| Christophe Fond, Group Vice President Retail | ||
| Claude Diversi, Member of the Management Board, Vice President International Sales (Europe, South America) | ||
| Paul Thompson, Group VP of Wholesale for the Region North and Central America and Member of the Management Board | ||
| Hansjuerg Emch, Group Vice President Medical, Member of the Management Board | ||
| Arnd Kaldowski, COO, Member of the Management Board | ||
| Martin Grieder, Vice President Phonak, Member of the Management Board | ||
| Hans Mehl, Group VP of Operations and Member of Management Board | ||
| Maarten Barmentlo, Member of the Management Board, Group Vice President Marketing | ||
| Stefan Launer, Member of the Management Board, Vice President Science & Technology | ||
| Andreas Vonlanthen, Member of the Management Board, Group Vice President Research & Development | ||
| Ronald Vis, Non-Executive Director | ||
| Andreas Rihs, Non-Executive Director | ||
| Franz Petermann, Member of the Management Board | ||
| Jan Metzdorff, Member of the Management Board | ||
| Albert Lim, Member of the Management Board, Vice President International Sales for the Asia / Pacific region | ||
| Thomas Bernhardsgrutter, Director Relations | ||
| Jinlong Wang, Non-Executive Director | ||
| Lynn Bleil, Non-Executive Director | ||
| Lukas Braunschweiler, Chairman of Management Board and CEO | ||
| Michael Jacobi, Non-Executive Director | ||
| Claudio Bartesaghi, Member of the Management Board, Group Vice President Corporate Human Resources, Corporate Communications | ||
| Birgit Conix, CFO Board |
Sonova Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Sonova Holding a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.29 | |||
| Return On Asset | 0.0879 | |||
| Profit Margin | 0.18 % | |||
| Operating Margin | 0.21 % | |||
| Current Valuation | 15.94 B | |||
| Shares Outstanding | 305.8 M | |||
| Shares Owned By Institutions | 0.01 % | |||
| Price To Earning | 45.95 X | |||
| Price To Book | 7.55 X | |||
| Price To Sales | 4.10 X |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sonova Holding AG. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for Sonova Pink Sheet analysis
When running Sonova Holding's price analysis, check to measure Sonova Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sonova Holding is operating at the current time. Most of Sonova Holding's value examination focuses on studying past and present price action to predict the probability of Sonova Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sonova Holding's price. Additionally, you may evaluate how the addition of Sonova Holding to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |